Pharmaceutical Technologies in Drug Discovery & Drug Development Workshop

The Department of Pharmaceutical Sciences at the UNMC College of Pharmacy hosted leaders from Novartis, AstraZeneca, Organon, Pace, Sannova Analytical, and Isha Therapeutics at the annual Pharmaceutical Technologies in Drug Discovery & Drug Development Workshop on March 7 and 8, 2022.

The workshop, aimed at graduate students and postdocs, provided an overview of the role of various functions in the evolving pharmaceutical/biotechnology industry associated with research and development (R&D) of novel drug, biologic and cell/gene therapies. In addition, the workshop covered the role of basic disciplines like chemistry, pharmacology, drug delivery, and biophysics in the industry-oriented R&D to bring novel therapies to patients. In addition to seminar style lectures, attendees had the opportunity to participate in panel discussions, career development sections, and the workshop culminated in a case study that evaluated preclinical and FDA application data of a new COVID therapeutic. We are looking forward to hosting this again – stay tuned!

Date and Place
March 7-8, 2022 (virtual)
Schedule of Events

Organizers: 
Aaron M Mohs, PhD (UNMC)
Yazen Alnouti, PhD (UNMC)
Jered Garrison, PhD (UNMC)
Gangadhar Sunkara, PhD (Novartis)

Host: Ram Mahato, PhD, Chairman, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198

Background:
The decades long basic research in chemistry, molecular biology, biophysics, drug delivery, polymer chemistry, etc. are now producing fruits in the form of novel drug therapies to treat various acute, chronic, genetic and rare diseases. Today, the pharmaceutical and biotechnology industry is rapidly evolving to adopt various forms of interventional drug therapies such as small molecules, proteins/peptide drugs, biologics, cell/gene therapies and drug-device combinations. In this phase of rapid evolution of the industry, a workshop like this would provide a platform to share the experiences between the leaders in the industry and curious minds of academia (graduate students, post-docs, physicians, faculty, etc.) who are part of this evolution process.

Objectives of this workshop:
The workshop will provide an overview of the role of various functions in the evolving pharmaceutical/biotechnology industry associated with research and development (R&D) of novel drug, biologic and cell/gene therapies. In addition, the workshop covers the role of basic disciplines like chemistry, pharmacology, drug delivery and biophysics in the industry oriented R&D to bring novel therapies to patients. There will be specific focus on the tools/technologies used at each stage of drug discovery and development. Breakout group/panel discussion sessions will be organized to simulate cross-functional strategy and decision-making process in the drug discovery and development.

Speakers:
Anand Subramony
Sandip Roy
Lisa Crandall
David Jones
Kavitha Bandi
Haiying Sun
Renee Bergeron
Gangadhar Sunkara
Manoj Jadhav